Research to Advance Vaccine Safety Program

by: Iola Bonggay

The Centers for Disease Control and Prevention, more commonly referred to as CDC, is a United States federal agency operating within the Department of Health and Human Services that is primarily responsible for safeguarding public health and safety by way of providing essential health-related information and forming partnerships with state health department and several other organizations.

The programs and activities that are launched by the CDC are in accordance to their agency mission, which is to "Collaborate to create the expertise, information, and tools that people and communities need to protect their health – through health promotion, prevention of disease, injury and disability, and preparedness for new health threats."

In keeping with this mission, the Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

The discovery of vaccines is considered as a great medical breakthrough as it has contributed to the successful eradication of naturally occurred smallpox, and a substantial reduction of certain disease conditions that are caused by measles, mumps, influenza, hepatitis, diphtheria, and several other infections.

The Research to Advance Vaccine Safety Program aims to boost this medical breakthrough by funding scientific studies that address potentially relevant vaccine safety concerns such as:

1) A human being's immunological and physiological responses to vaccine and vaccine components.

  (continued...)

Research to Advance Vaccine Safety Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on grants for youth programs and home improvement grants.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Advanced Neural Prosthetics Research and Development Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to establish the Advanced Neural Prosthetics Research and Development Program.

---